US · Healthcare · Medical Devices
EPS came in at -0.07 against a street estimate of -0.06 — a miss of 16.7%.
Analysts rate Apyx Medical Inc a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $6.60.
| Fund | Stake |
|---|---|
| Nantahala Capital Management, LLC | 8.17% |
| Archon Capital Management LLC | 6.28% |
| Royce & Associates, LP | 6.20% |
| Vanguard Capital Management, LLC | 3.69% |
| Essex Investment Management Company, LLC | 2.70% |
| AIGH Capital Management, LLC | 2.68% |
| Silverberg Bernstein Capital Management LLC | 2.47% |
| Commonwealth Equity Services, LLC | 1.54% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apyx Medical Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.